• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Denali Therap(DNLI.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec30
Denali Therapeutics Reports Positive Clinical Trial Results for Hunter Syndrome Treatment tividenofusp alfa
13:00
Dec10
Denali Therapeutics Floats IPO to Raise $200 Million
23:42
Dec4
Denali Therapeutics and Royalty Pharma Reach $275 Million Financing Agreement
12:02
H.C. Wainwright Analyst Maintains Buy Rating on Denali Therapeutics with Price Target
08:02
Nov17
Stifel Nicolaus Analyst Maintains Denali Therapeutics Buy Rating
12:22
Nov11
BTIG Analyst Reiterates Buy Rating on Denali Stock
11:56

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -126.9 M, EPS -0.7359

Aug11
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -124.12 M, EPS -0.7239

May6
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -132.97 M, EPS -0.7765

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More